Editor Anna Rose Welch at Biosimilar Development discusses the role MSLs play in the pharma industry, and how it will evolve.
Quite often in this industry, we refer to education as a singular initiative put together by one organization or a collaborative effort amongst several stakeholder organizations. Each biosimilar company is no doubt involved in putting together some form of stakeholder-centric education, whether it be social media campaigns, FAQ-type handouts, or a biosimilar-specific educational portal on a company’s website. But little attention is paid to the behind-the-scenes, day-to-day educational efforts carried out by companies’ medical science liaison (MSL) teams.
Read more at Biosimilar Development, and learn more about our report Benchmarking the Pharma Industry’s Medical Science Liaison (MSL) Function.
